Actelion founder joins Wellington as venture partner

Thomas Widmann, the founder of one of Europe's most successful life science start-ups, has joined Munich private equity firm Wellington Partners as a venture partner, to help build its portfolio of companies.

Widmann was a member of the team that founded Actelion, a Swiss biotechnology company, in 1997. Wellington Partners supported Actelion through its initial public offering in 2000.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump